Nanoviricides Inc (NNVC)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 06/30
| 06-2024 | 03-2024 | 12-2023 | 09-2023 | 06-2023 | |
| Operating Expenses | 2,391 | 1,908 | 2,185 | 2,032 | 3,676 |
| Operating Income | -2,391 | -1,908 | -2,185 | -2,032 | -3,676 |
| Interest Expense | 0 | 0 | 13 | 37 | 0 |
| Other Income | 35 | 54 | 83 | 99 | 107 |
| Pre-tax Income | -2,356 | -1,855 | -2,115 | -1,969 | -3,570 |
| Net Income Continuous | -2,356 | -1,855 | -2,115 | -1,969 | -3,570 |
| Net Income | $-2,356 | $-1,855 | $-2,115 | $-1,969 | $-3,570 |
| EPS Basic Total Ops | -0.19 | -0.16 | -0.18 | -0.17 | -0.30 |
| EPS Basic Continuous Ops | -0.19 | -0.16 | -0.18 | -0.17 | -0.31 |
| EPS Diluted Total Ops | -0.19 | -0.16 | -0.18 | -0.17 | -0.30 |
| EPS Diluted Continuous Ops | -0.19 | -0.16 | -0.18 | -0.17 | -0.31 |
| EPS Diluted Before Non-Recurring Items | -0.19 | -0.16 | -0.18 | N/A | N/A |
| EBITDA(a) | $-2,201 | $-1,718 | $-1,995 | $-1,843 | $-3,488 |